report_id=bw10050 Heart failure therapeutics are observing an upward trajectory, spurred by an aging population increasingly susceptible to cardiac conditions. Advances in medical technology are ...

WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) has announced a significant advancement in its cardiovascular ...

In response to the increased utilization of Barostim therapy and the strong evidence supporting its clinical outcomes, the ...

USV introduces OnArni, a cost-effective heart failure medication at ₹8 per tablet, improving adherence and health outcomes.

Most of us are familiar with Ozempic as a treatment for type 2 diabetes and obesity but now, new findings suggest that ...

Women are still being excluded from cardiovascular research trials, and it has a lasting impact on heart disease treatment ...

Several observations from preclinical and short-term clinical studies support a role for sildenafil in the treatment of heart failure patients. The following discussion briefly considers each of ...

In a new study in mice, Junco Warren, assistant professor at the Fralin Biomedical Research Institute, offers findings that ...

A new American Heart Association scientific statement suggests addressing cardiovascular health earlier in life may reduce the risk of stroke and help preserve thinking and memory later in life.

I recently attended an educational event where I’d been asked to spend the afternoon teaching some of my favourite subjects, such as uncertainty and complexity. The morning was devoted to hardcore ...

Recent research is looking at the way in which cardiovascular issue may play into the development of dementia, with one study suggesting that heparin, a common anticoagulant, may help delay ...

Most physicians adhere to guideline-directed medical therapies for HFrEF based on the 2021 European Society of Cardiology HF guidelines.